Prevalence of subclinical contributors to low bone mineral density and/or fragility fracture

European Journal of Endocrinology

Volumn 169, Issue 2, 2013, Pages 225-237

  Eller Vainicher, Cristina ^a   Cairoli, Elisa ^a   Zhukouskaya, Volha V ^a   Morelli, Valentina ^a   Palmieri, Serena ^a   Scillitani, Alfredo ^b   Beck Peccoz, Paolo ^a   Chiodini, Iacopo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE;

ADULT; AGE; AGED; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CELIAC DISEASE; DEXAMETHASONE SUPPRESSION TEST; DISEASE ASSOCIATION; FEMALE; FRAGILITY FRACTURE; HORMONE URINE LEVEL; HUMAN; HYPERCORTISOLISM; IDIOPATHIC HYPERCALCIURIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; VITAMIN D DEFICIENCY;

ABSORPTIOMETRY, PHOTON; AGED; BONE DENSITY; CALCIUM; FEMALE; FEMUR NECK; FRACTURES, BONE; HUMANS; HYDROCORTISONE; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; VITAMIN D; WRIST;

EID: 84880958178     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0102     Document Type: Article

References (48)

1. Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clinic Proceedings 2002 77 453-468. (doi:10.4.65/77.5.453)
2. Hofbauer LC, Hamann C & Ebeling PR. Approach to the patient with secondary osteoporosis. European Journal of Endocrinology 2010 162 1009-1020. (doi:10.1530/EJE-10-0015)
3. Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D & Luckey M. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. Journal of Clinical Endocrinology and Metabolism 2002 87 4431-4437. (doi:10.1210/jc.2002-020275)
4. Deutschmann HA, Weger M, Weger W, Kotanko P, Deutschmann MJ & Skrabal F. Search for occult secondary osteoporosis: Impact of identified possible risk factors on bone mineral density. Journal of Internal Medicine 2002 252 389-397. (doi:10.1046/j.1365-2796.2002.01040.x)
5. Romagnoli E, Del Fiacco R, Russo S, Piemonte S, Fidanza F, Colapietro F, Diacinti D, Cipriani C & Minisola S. Secondary osteoporosis in men and women: Clinical challenge of an unresolved issue. Journal of Rheumatology 2011 38 1671-1679. (doi:10.3899/jrheum.110030)
6. Dumitrescu B, van Helden S, ten Broeke R, Nieuwenhuijzen-Kruseman A, Wyers C, Udrea G, van der Linden S & Geusens P. Evaluation of patients with a recent clinical fracture and osteoporosis, a multidisciplinary approach. BMC Musculoskeletal Disorders 2008 9 109-119. (doi:10.1186/1471-2474-9-109)
7. Bours SP, van Geel TA, Geusens PP, Janssen MJ, Janzing HM, Hoffland GA, Willems PC & van den Bergh JP. Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture. Journal of Clinical Endocrinology and Metabolism 2011 96 1360-1367. (doi:10.1210/jc.2010-2135)
8. Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, Wilkins M et al. Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 2009 62 105-108. (doi:10.1016/j.maturitas.2008. 11.022)
9. Giannini S, Nobile M, Dalle Carbonare L, Lodetti MG, Sella S, Vittadello G, Minicuci N & Crepaldi G. Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. European Journal of Endocrinology 2003 149 209-213. (doi:10.1530/eje.0.1490209)
10. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, McMahon DJ & Bilezikian JP. Increased bone mineral density following parathyroidectomy in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 1995 80 729-734. (doi:10.1210/jc.80.3.729)
11. Diamond T, Vine J, Smart R & Butler P. Thyrotoxic bone disease in women: A potentially reversible disorder. Annals of Internal Medicine 1994 120 8-11. (doi:10.7326/0003-4819-120-1-199401010-00002)
12. Pazianas M, Butcher GP, Subhani JM, Finch PJ, Ang L, Collins C, Heaney RP, Zaidi M & Maxwell JD. Calcium absorption and bone mineral density in celiacs after long term treatment with glutenfree diet and adequate calcium intake. Osteoporosis International 2005 16 56-63. (doi:10.1007/s00198-004-1641- 2)
13. Morelli V, Eller-Vainicher C, Salcuni AS, Coletti F, Iorio L, Muscogiuri G, Della Casa S, Arosio M, Ambrosi B, Beck-Peccoz P et al. Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: A multicenter longitudinal study. Journal of Bone and Mineral Research 2011 26 1816-1821. (doi:10.1002/jbmr.398)
14. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A & National Osteoporosis Guideline Group. Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporosis International 2008 19 1395-1408. (doi:10.1007/s00198-008-0712-1)
15. Adami S, Romagnoli E, Carnevale V, Scillitani A, Giusti A, Rossini M, Gatti D, Nuti R & Minisola S. Guidelines on prevention and treatment of vitamin D deficiency. Reumatismo 2011 63 129-147. (doi:10.4081/reumatismo.2011. 129)
16. Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, Santini SA, Guglielmi G, Carnevale V & Scillitani A. Subclinical hypercortisolism among outpatients referred for osteoporosis. Annals of Internal Medicine 2007 147 541-548. (doi:10.7326/0003-4819-147-8-200710160-00006)
17. Jamal SA, Leiter RE, Bayoumi AM, Bauer DC & Cummings SR. Clinical utility of laboratory testing in women with osteoporosis. Osteoporosis International 2005 16 534-540. (doi:10.1007/ s00198-004-1718-y)
18. Odabasi E, Turan M, Tekbas F & Kutlu M. Evaluation of secondary causes that may lead to bone loss in women with osteoporosis: A retrospective study. Archives of Gynecology and Obstetrics 2009 279 863-867. (doi:10.1007/s00404-008-0846-6)
19. Cerdá Gabaroi D, Peris P, Monegal A, Albaladejo C, Martínez MA, Muxí A, Martínez de Osaba MJ, Surís X & Guanabens N. Search for hidden secondary causes in postmenopausal women with osteoporosis. Menopause 2010 17 135-139. (doi:10.1097/gme. 0b013e3181ade8e5)
20. Ryan CS, Petkov VI & Adler RA. Osteoporosis in men: The value of laboratory testing. Osteoporosis International 2011 22 1845-1853. (doi:10.1007/s00198-010-1421-0)
21. Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, Rao DS, Rubin MR, Goltzman D, Silverberg SJ et al. Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the Third International Workshop. Journal of Clinical Endocrinology and Metabolism 2009 94 340-350. (doi:10.1210/ jc.2008-1758)
22. Worcester EM & Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Seminars in Nephrology 2008 28 120-132. (doi:10.1016/j.semnephrol.2008.01.005)
23. Leib ES, Lewiecki EM, Binkley N & Hamdy RC. Official positions of the International Society for Clinical Densitometry. Journal of Clinical Densitometry 2004 97 107-110.
24. Craver L, Marco MP, Martinez I, Rue M, Borras M, Martín ML, Sarró F, Valdivielso JM & Fernández E. Mineral metabolism parameters throughout chronic kidney diseases stages 1-5-achievement of K/DOQI target ranges. Nephrology, Dialysis, Transplantation 2007 22 1171-1176. (doi:10.1093/ndt/gfl718)
25. National Institute on Alcohol Abuse and Alcoholism, U.S. Dept of Health and Human Services. Description for standard drinks chart (available: Http://pubs.niaaa.nih.gov/publications/Practitioner/ PocketGuide/pocket-guide2. htm, accessed 2 September 2009), 2005.
26. Varenna M, Binelli L, Zucchi F, Ghiringhelli D & Sinigaglia L. Unbalanced diet to lower serum cholesterol level is a risk factor for postmenopausal osteoporosis and distal forearm fracture. Osteoporosis International 2001 12 296-301. (doi:10.1007/s001980170119)
27. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S & Meunier PJ. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International 1997 7 439-443. (doi:10.1007/s001980050030)
28. Heaney RP, Dowell MS, Hale CA & Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. Journal of the American College of Nutrition 2003 22 142-146.
29. Looker AC, Johnston CC Jr, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP & Lindsay RL. Prevalence of low bone density in older U.S. women from NHANES III. Journal of Bone and Mineral Research 1995 10 796-802. (doi:10.1002/jbmr.5650100517)
30. Genant HK, Wu CY, van Knijk C & Nevitt M. Vertebral fracture assessment using a semi-quantitative technique. Journal of Bone and Mineral Research 1993 8 1137-1148. (doi:10.1002/jbmr. 5650080915)
31. Crans GG, Genant HK & Krege JH. Prognostic utility of a semiquantitative spinal deformity index. Bone 2005 37 175-179. (doi:10.1016/j.bone.2005.04.003)
32. UpToDate calculator. In Calcium Correction in Hypoalbuminemia, version 18.2. Waltham, MA: Wolters Kluwer-Health (available: Www.uptodate.com, accessed 2 September 2009), 2010.
33. Stenson WF, Newberry R, Lorenz R, Baldus C & Civitelli R. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Archives of Internal Medicine 2000 165 393-399. (doi:10.1001/archinte.165.4.393)
34. Chiodini I. Diagnosis and treatment of subclinical hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2011 96 1223-1236. (doi:10.1210/jc.2010-2722)
35. WangC, Nieschlag E, Swerdloff R, BehreHM, HellstromWJ,Gooren LJ, Kaufman JM, Legros J-J, Lunenfeld B, Morales A et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. European Journal of Endocrinology 2008 159 507-514. (doi:10.1530/EJE-08-0601)
36. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group. British Journal of Haematology 2003 121 749-757. (doi:10.1046/j.1365-2141.2003.04355.x)
37. Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D et al. Monoclonal gammopathy of undetermined significance: A consensus statement. British Journal of Haematology 2010 150 28-38. (doi:10.1111/j.1365-2141.2010.08207.x)
38. DRI dietary reference intakes. Food and Nutrition Board of the Institute of Medicine of the National Academies. Washington DC, USA: The National Academies Press (www.nap.edu), 2010.
39. Carnevale V, Nieddu L, Romagnoli E, Battista C, Mascia ML, Chiodini I, Eller-Vainicher C, Frusciante V, Santini SA, La Porta M et al. Regulation of PTH secretion by 25-hydroxyvitamin D and ionized calcium depends on vitamin D status: A study in a large cohort of healthy subjects. Bone 2010 47 626-630. (doi:10.1016/j.bone.2010.06.013)
40. Carnevale V, Modoni S, Pileri M, Di Giorgio A, Chiodini I, Minisola S, Vieth R & Scillitani A. Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: Seasonal and gender differences. Osteoporosis International 2001 12 1026-1030. (doi:10.1007/s001980170012)
41. Isaia G, Giorgino R, Rini GB, Bevilacqua M, Maugeri D & Adami S. Prevalence of hypovitaminosis D in elderly women in Italy: Clinical consequences and risk factors. Osteoporosis International 2003 14 577-582. (doi:10.1007/s00198-003-1390-7)
42. Adami S, Bertoldo F, Brandi ML, Cepollaro C, Filipponi P, Fiore E, Frediani B, Giannini S, Gonnelli S, Isaia GC et al. Guidelines for the diagnosis, prevention and treatment of osteoporosis. Reumatismo 2009 61 260-284.
43. Stein E & Shane E. Secondary osteoporosis. Endocrinology and MetabolismClinics of North America 2003 1 115-134. (doi:10.1016/ S0889-8529(02)00062-2)
44. Eller-Vainicher C, Morelli V, Ulivieri FM, Palmieri S, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Scillitani A, Beck-Peccoz P et al. Bone quality as measured by trabecular bone score (TBS) in patients with adrenal incidentalomas with and without subclinical hypercortisolism. Journal of Bone and Mineral Research 2012 27 2223-2230. (doi:10.1002/jbmr.1648)
45. Kann P, Laudes M, Piepkorn B, Heintz A & Beyer J. Suppressed levels of serum cortisol after high-dose oral dexamethasone administration differ between healthy postmenopausal females and patients with established primary vertebral osteoporosis. Clinical Rheumatology 2001 20 25-29. (doi:10.1007/s100670 170099)
46. Abrahamsen B, Andersen I, Christensen SS, Skov Madsen J & Brixen K. Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: Retrospective, cross sectional study. BMJ 2005 330 818-820. (doi:10.1136/bmj.38376. 401701.8F)
47. Kristinsson SY, Tang M, Pfeiffer RM, Bjorkholm M, Blimark C, Mellqvist UH, Wahlin A, Turesson I & Landgren O. Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: A population-based study. Blood 2010 116 2651-2655. (doi:10.1182/blood-2010-04-282848)
48. Pepe J, Petrucci MT, Nofroni I, Fassino V, Diacinti D, Romagnoli E & Minisola S. Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. British Journal of Haematology 2006 134 485-490. (doi:10.1111/j.1365-2141. 2006.06217.x)